CONSTITUENT REPORT
Terpinen-4-ol
Terpinen-4-ol is the signature monoterpene alcohol of tea tree oil and a recurring secondary constituent in lavender, marjoram, plai, petitgrain, and several conifer or citrus-adjacent oils in the AromaForge archive. Compared with many essential-oil constituents, it has a relatively substantial literature trail covering identity, antimicrobial testing, immune-cell signaling, and topical tea-tree-related inflammation models. The evidence is still mostly cell, animal, or topical-preclinical rather than clinical proof, so it should be framed as a well-studied aroma constituent with early pharmacology and real contact-allergy context rather than as a medical ingredient.
Chemical identity and composition
PubChem identifies terpinen-4-ol as CID 11230 with formula C10H18O and IUPAC name 4-methyl-1-propan-2-ylcyclohex-3-en-1-ol. PubChem synonym data link the common trade and literature names 4-terpineol, terpin-4-ol, and 4-carvomenthenol. In archive oil profiles, terpinen-4-ol ranges from a chemotype-defining dominant constituent in tea tree and plai to a meaningful secondary marker in lavender, petitgrain, mastic leaf, and nutmeg.
Aroma and practical use
- Use the recorded fresh, herbal, tea tree-like, camphoraceous, woody, herbaceous descriptors to explore a blend's scent character; perceived strength also depends on the other ingredients.
- Compare the recorded goal signals with the intended purpose, while keeping model assumptions separate from observed study outcomes.
- Review the flagged use concerns across every contributing oil and the selected dilution.
- Read the route, preparation and experimental context before using a study finding to choose an oil.
Reported benefits and effects
Findings retain their study context. An animal or laboratory result describes that experiment.
A 2000 monocyte study reported that terpinen-4-ol, but not the other tested water-soluble tea tree constituents, suppressed LPS-induced TNF-alpha, IL-1beta, IL-8, IL-10, and PGE2 production in activated human monocytes.
A 2000 monocyte study reported that terpinen-4-ol, but not the other tested water-soluble tea tree constituents, suppressed LPS-induced TNF-alpha, IL-1beta, IL-8, IL-10, and PGE2 production in activated human monocytes.
This experimental finding does not establish benefit, dose or safety in people using this blend.
A 2002 mouse study found that topical tea tree oil reduced swelling in a contact-hypersensitivity model and concluded that terpinen-4-ol and alpha-terpineol could regulate the edema associated with the efferent phase of the response.
A 2002 mouse study found that topical tea tree oil reduced swelling in a contact-hypersensitivity model and concluded that terpinen-4-ol and alpha-terpineol could regulate the edema associated with the efferent phase of the response.
This experimental finding does not establish benefit, dose or safety in people using this blend.
A 2008 Letters in Applied Microbiology paper reported that terpinen-4-ol showed significantly greater bacteriostatic and bactericidal activity than tea tree oil against MRSA and coagulase-negative staphylococci, while neither agent was toxic to human fibroblasts over 24 hours at the tested concentrations.
A 2008 Letters in Applied Microbiology paper reported that terpinen-4-ol showed significantly greater bacteriostatic and bactericidal activity than tea tree oil against MRSA and coagulase-negative staphylococci, while neither agent was toxic to human fibroblasts over 24 hours at the tested concentrations.
This experimental finding does not establish benefit, dose or safety in people using this blend.
How it contributes to goal calculations
Model markers guide the formulation score. They are separate from the source findings above.
Use concerns and concentration limits
Sensitization concernFlagged
Flagged in the constituent reference; assess the source, route and finished-product concentration.
Phototoxicity concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Oxidation concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Penetration enhancementNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
A recorded constituent reference, not a recommended oil dilution. Product category, source applicability and all contributing oils must be checked before use.
unverified reference · No source provenance attachedTea tree oil contact-allergy review literature identifies fresh tea tree oil as a weak to moderate sensitizer, with oxidation increasing allergenic potency; this is relevant context for terpinen-4-ol-rich materials even though the review did not identify terpinen-4-ol as the major sensitizer.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
No direct public citation is attached to this entry.
The 2008 skin-isolate study reported no fibroblast toxicity over 24 hours at the tested concentrations, but that should not be treated as a general human safety clearance.
This experimental finding does not establish benefit, dose or safety in people using this blend.
No direct public citation is attached to this entry.
A constituent-specific modern human dermal threshold for isolated terpinen-4-ol was not verified in this pass.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
No direct public citation is attached to this entry.
Constituents it may interact with
These are research candidates recorded in the interaction matrix. They do not add a proven-amplification bonus to the score.
TerpinoleneAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · effect
No source citation attached.
Read Terpinolene report →alpha-TerpineolOpposing candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · effect
No source citation attached.
Read alpha-Terpineol report →1,8-cineoleAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · effect
No source citation attached.
Read 1,8-cineole report →alpha-TerpineolAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · whole_oil
No source citation attached.
Read alpha-Terpineol report →p-CymeneOpposing candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · effect
No source citation attached.
Read p-Cymene report →LinaloolNeutral record
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · effect
No source citation attached.
Read Linalool report →MyrceneAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · effect
No source citation attached.
Read Myrcene report →alpha-TerpineolAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · effect
No source citation attached.
Read alpha-Terpineol report →Decanoic acidAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
mixed · effect
No source citation attached.
Read Decanoic acid report →How the effects were investigated
suppressed_proinflammatory_mediator_production
In LPS-activated human monocytes, terpinen-4-ol suppressed production of TNF-alpha, IL-1beta, IL-8, IL-10, and PGE2, making cytokine and eicosanoid modulation the clearest direct mechanism signal located.
This experimental finding does not establish benefit, dose or safety in people using this blend.
reduced_edema_in_contact_hypersensitivity_model
Topical terpinen-4-ol was identified as one of the tea-tree constituents that regulated edema during the efferent phase of a mouse contact-hypersensitivity response.
This experimental finding does not establish benefit, dose or safety in people using this blend.
What this report cannot establish
- A reported constituent percentage does not establish an effective human therapeutic dose or the amount absorbed into the body.
- The presence of a constituent does not guarantee a clinical benefit, rash treatment or sleep improvement from a custom blend.
- An unflagged concern or missing use limit does not establish safety for ingestion, inhalation, skin exposure or a particular person.
- A candidate constituent interaction does not establish that two oils amplify one another at the selected proportions.
- Constituent descriptors alone do not establish a precise top, heart or base lifetime in a finished blend.
Known data gaps (6)
- Most terpinen-4-ol efficacy evidence remains in vitro, ex vivo, or animal-model research rather than human clinical studies.
- Many safety discussions are available only through tea tree oil mixture reviews rather than isolated-compound exposure studies.
- A validated constituent-specific inhalation or neat-use safety threshold was not confirmed in this pass.
- The numeric dermal reference lacks source provenance; a verified flag alone is insufficient.
- Some findings do not record an explicit exposure route; consult the linked study before applying them to a use.
- Interaction candidates lack an attached source citation and remain unqualified.